| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.36▼ | 2.43▼ | 2.46▼ | 2.58▼ | 2.51▼ |
| MA10 | 2.42▼ | 2.47▼ | 2.54▼ | 2.55▼ | 2.60▼ |
| MA20 | 2.45▼ | 2.56▼ | 2.66▼ | 2.59▼ | 3.12▼ |
| MA50 | 2.48▼ | 2.64▼ | 2.60▼ | 2.75▼ | 2.57▼ |
| MA100 | 2.57▼ | 2.59▼ | 2.60▼ | 3.07▼ | 4.61▼ |
| MA200 | 2.62▼ | 2.63▼ | 2.54▼ | 2.76▼ | 8.52▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.013▼ | -0.019▼ | -0.040▼ | 0.005▲ | -0.109▼ |
| RSI | 22.772▼ | 24.831▼ | 27.671▼ | 41.174▼ | 43.272▼ |
| STOCH | 6.803▼ | 11.614▼ | 8.281▼ | 33.132 | 12.185▼ |
| WILL %R | -93.750▼ | -96.970▼ | -97.778▼ | -98.538▼ | -96.217▼ |
| CCI | -107.457▼ | -212.933▼ | -128.134▼ | -153.605▼ | -58.436 |
|
Thursday, March 19, 2026 04:49 AM
Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such ...
|
|
Thursday, March 19, 2026 03:33 AM
Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for ...
|
|
Monday, March 16, 2026 05:11 AM
Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 19/03/26 | 2.42 | 2.42 | 2.345 | 2.355 | 70,487 |
| 18/03/26 | 2.72 | 2.755 | 2.452 | 2.47 | 658,276 |
| 17/03/26 | 2.85 | 3.0288 | 2.70 | 2.74 | 363,044 |
| 16/03/26 | 2.54 | 2.90 | 2.54 | 2.83 | 667,466 |
| 13/03/26 | 2.44 | 2.56 | 2.44 | 2.52 | 234,141 |
| 12/03/26 | 2.50 | 2.57 | 2.43 | 2.46 | 229,313 |
| 11/03/26 | 2.60 | 2.68 | 2.445 | 2.50 | 432,546 |
| 10/03/26 | 2.62 | 2.71 | 2.555 | 2.58 | 223,136 |
| 09/03/26 | 2.49 | 2.575 | 2.4101 | 2.57 | 390,209 |
| 06/03/26 | 2.51 | 2.54 | 2.455 | 2.49 | 163,491 |
|
|
||||
|
|
||||
|
|